Furthermore, mice treated with IL-33 developed histopathological changes in the lungs such as lining hypertrophy, goblet cell hypertrophy, and mucus hypersecretion, which are typical for COPD patients (11). The gene discussed is IL33; the disease is chronic obstructive pulmonary disease.